{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:43:06Z","timestamp":1790142186901,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/01.mjt.0000433937.07244.e1","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T15:44:45Z","timestamp":1381160685000},"page":"e151-e157","source":"Crossref","is-referenced-by-count":36,"title":["Colchicine"],"prefix":"10.1097","volume":"22","author":[{"given":"John","family":"Stack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1906","article-title":"A concise history of gout and hyperuricemia and their treatment.","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R2-14-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":". Colchicine poisoning: the dark side of an ancient drug.","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"R3-14-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"R4-14-20210202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells.","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body.","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11882-011-0207-6","article-title":"The emerging role of interleukin-1 in autoinflammatory diseases.","volume":"11","author":"Lane","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"R8-14-20210202","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1002\/art.23069","article-title":"Urate crystals, inflammation, and colchicine.","volume":"58","author":"McCarty","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tcb.2006.08.002","article-title":"Microtubule motors at the intersection of trafficking and transport.","volume":"16","author":"Caviston","year":"2006","journal-title":"Trends Cell Biol"},{"key":"R10-14-20210202","first-page":"377","article-title":"Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases Med Hypotheses.","volume":"51","author":"Ben-Chetrit","year":"1998","journal-title":""},{"key":"R11-14-20210202","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":". Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"R12-14-20210202","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.","volume":"153","author":"Chia","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R13-14-20210202","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI116759","article-title":". Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.","volume":"92","author":"Roberge","year":"1993","journal-title":"J Clin Invest"},{"key":"R14-14-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":". Gout-associated uric acid crystals activate the NALP3 inflammasome.","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R15-14-20210202","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-81-6-792","article-title":"Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study.","volume":"81","author":"Goldstein","year":"1974","journal-title":"Ann Intern Med"},{"key":"R16-14-20210202","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":". Colchicine therapy for familial mediterranean fever. A double-blind trial.","volume":"291","author":"Dinarello","year":"1974","journal-title":"N Engl J Med"},{"key":"R17-14-20210202","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":". A controlled trial of colchicine in preventing attacks of familial mediterranean fever.","volume":"291","author":"Zemer","year":"1974","journal-title":"N Engl J Med"},{"key":"R18-14-20210202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":". Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.","volume":"38","author":"Ozen","year":"2011","journal-title":"J Rheumatol"},{"key":"R19-14-20210202","first-page":"2845","article-title":"Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer Arthritis Rheum.","volume":"62","author":"Neogi","year":"2010","journal-title":""},{"key":"R20-14-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":". Does colchicine work The results of the first controlled study in acute gout.","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"R21-14-20210202","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":". EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R22-14-20210202","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":". High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R23-14-20210202","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":". Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"R24-14-20210202","first-page":"9","article-title":". Prevalence of ischaemic heart disease in patients with familial Mediterranean fever.","volume":"3","author":"Langevitz","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"R25-14-20210202","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":". Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"R26-14-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":". Low-dose colchicine for secondary prevention of cardiovascular disease.","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R27-14-20210202","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":". COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placeo-controlled trial.","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"key":"R28-14-20210202","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":". Colchicine reduces postoperative atrial fibrillation: results of the COlchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy.","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"R29-14-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2013.03.025","article-title":". Rationale and design of the colchicine for prevention of the postpericardiotomy syndrome and postoperative atrial fibrillation (COPPS-2 trial): a randomized, placebocontrolled, multicentre study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions and postoperative atrial fibrillation.","volume":"166","author":"Imazio","year":"2013","journal-title":"Am Heart J"},{"key":"R30-14-20210202","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1161\/CIRCULATIONAHA.104.475194","article-title":". Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation.","volume":"111","author":"Ishii","year":"2005","journal-title":"Circulation"},{"key":"R31-14-20210202","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":". Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"key":"R32-14-20210202","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today.","volume":"73","author":"Niel","year":"2006","journal-title":"Joint Bone Spine"},{"key":"R33-14-20210202","first-page":"710","article-title":". Colchicine disposition in patients with familial Mediterranean fever with renal impairment.","volume":"21","author":"Ben-Chetrit","year":"1994","journal-title":"J Rheumatol"},{"key":"R34-14-20210202","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":". Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4P-glycoprotein inhibitors.","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R35-14-20210202","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.clinthera.2012.08.007","article-title":"Effects of grapefruit and seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects.","volume":"34","author":"Wason","year":"2012","journal-title":"Clin Ther"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.mjt.0000433937.07244.e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:28:38Z","timestamp":1620941318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201509000-00014"}},"subtitle":["New Insights to an Old Drug"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mjt.0000433937.07244.e1","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}